Criticism is coming out that top-ranked domestic pharmaceutical companies are falling into income dealer of multinational pharmaceutical companies

There are growing concerns because many listed domestic pharmaceutical companies show increasing sales through importing products of multinational pharmaceutical companies.

According to the analysis result of current status of sales of 44 listed pharmaceutical companies in the KOSPI and KOSDAQ who handed in audit report to the Financial Supervisory Service in 2013, it turned out that sales of ...